Eli Lilly (LLY) EV to CFO (2009 - 2026)
Eli Lilly's EV to CFO was 35.43 in Q3 2026, down 20.0% from 44.30 a year earlier and down 11.2% from the prior quarter.
Powered by 
Analysis
Eli Lilly (LLY) EV to CFO (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Eli Lilly's EV to CFO was 34.73 through Sep 30, 2026, down 20.5% year-over-year; for FY2025, it came in at 59.87, down 27.5% from FY2024.
- In earlier years, EV to CFO was 82.63 in FY2024 (-36.4%), 129.96 in FY2023 (+185.3%), 45.56 in FY2022 (+29.4%) and 35.21 in FY2021 (+44.5%).
- The Q3 2026 figure marks the lowest quarterly EV to CFO since Q1 2022.
- Compared with a year earlier, EV to CFO has declined for eight straight quarters, with an average decline of 45.7% over the last eight quarters.
- The best year-over-year quarter for EV to CFO over five years was Q1 2024 (growth of 322.4%); the worst was Q3 2025 (a decline of 68.1%).
- Per Business Quant data, LLY's EV to CFO in the three quarters before Q3 2026 was 39.89 (Q2 2026), 42.04 (Q1 2026) and 59.87 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn |
| 10 | Vertex Pharmaceuticals | 138.78 Bn | 110.77 Bn | 2.91 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 35.43 |
| Jun 30, 2026 | 39.89 |
| Mar 31, 2026 | 42.04 |
| Dec 31, 2025 | 59.87 |
| Sep 30, 2025 | 44.30 |
| Jun 30, 2025 | 67.13 |
| Mar 31, 2025 | 83.67 |
| Dec 31, 2024 | 82.63 |
| Sep 30, 2024 | 138.86 |
| Jun 30, 2024 | 190.08 |
| Mar 31, 2024 | 200.49 |
| Dec 31, 2023 | 129.96 |
| Sep 30, 2023 | 81.66 |
| Jun 30, 2023 | 70.88 |
| Mar 31, 2023 | 47.46 |
| Dec 31, 2022 | 45.56 |
| Sep 30, 2022 | 37.22 |
| Jun 30, 2022 | 40.19 |
| Mar 31, 2022 | 32.92 |
| Dec 31, 2021 | 35.21 |
API Access
Eli Lilly EV to CFO API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=LLY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ev-to-cfo", "ticker": "LLY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=LLY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();